KNPYX
Price
$117.68
Change
+$1.64 (+1.41%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

KNPYX vs RPTIX

Header iconKNPYX vs RPTIX Comparison
Open Charts KNPYX vs RPTIXBanner chart's image
Kinetics Paradigm Instl
Price$117.68
Change+$1.64 (+1.41%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
KNPYX vs RPTIX Comparison Chart
Loading...
VS
KNPYX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNPYX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. KNPYX (1.1B). RPTIX pays higher dividends than KNPYX: RPTIX (0.18) vs KNPYX (0.00). KNPYX was incepted earlier than RPTIX: KNPYX (19 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. KNPYX (0.00). RPTIX has a lower initial minimum investment than KNPYX: RPTIX (500000) vs KNPYX (1000000). KNPYX annual gain was more profitable for investors over the last year : 42.49 vs. RPTIX (14.81). KNPYX return over 5 years is better than : 134.92 vs. RPTIX (15.09).
KNPYXRPTIXKNPYX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years9 years-
Gain YTD58.8129.127644%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B31.4B3%
Annual Yield % from dividends0.000.18-
Returns for 1 year42.4914.81287%
Returns for 3 years61.39-13.57-452%
Returns for 5 years134.9215.09894%
Returns for 10 years239.52N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp